Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 50S ribosomal protein is a component of the large (50S) subunit of the prokaryotic ribosome, which, together with the small (30S) subunit, forms the complete 70S ribosome in bacteria and archaea. The 50S subunit is primarily responsible for catalyzing peptide bond formation during protein synthesis and plays a central role in translation. It consists of ribosomal RNAs (23S and 5S rRNA) and over 30 distinct proteins. The bacterial/archaeal 50S subunit is targeted by several classes of antibiotics—including macrolides, chloramphenicol, clindamycin, and pleuromutilins—which inhibit its function by binding specific sites unique to prokaryotes.
Inhibition of protein synthesis by binding to the 50S ribosomal subunit
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 50S Ribosomal Protein.